This Visio flowchart shows how forms come due when the cellular therapy is first and there is combined follow up for the subsequent HCT.
Question | F4100 | F2450 (when TED level HCT | F2100 (when CRF level HCT) |
---|---|---|---|
Subsequent HCT/CT | Disabled | ||
Best response to CT | Disabled when disease form present | ||
Peripheral Blood Count Recovery | Disabled | ||
Relapse | Disabled when disease form present | Disabled when disease form present | |
GVHD | Disabled | ||
Current hematologic findings | Disabled | ||
Infection | Disabled | Disabled | |
New malignancy | Disabled | Disabled | |
Disease assessment at time of best response | Disabled when disease form present | ||
COVID vaccine | Disabled | Disabled | |
New malignancy | Disabled | Disabled | |
Post-HCT therapy | Disabled when disease form present | ||
Relapse | Disabled when disease form present | Disabled when disease form present | |
Intervention | Disabled when disease form present | ||
Current disease status | Disabled when disease form present | ||
Pregnancy | Disabled |
Last modified:
Sep 23, 2022